BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
©Author(s) (or their employer(s)) 2026.
World J Clin Pediatr. Mar 9, 2026; 15(1): 116331
Published online Mar 9, 2026. doi: 10.5409/wjcp.v15.i1.116331
Figure 4
Figure 4 Meta-analysis. A: Meta-analysis for high-frequency (HF) heart-rate variability. Forest plot showing the effect of omega-3 supplementation on HF power, representing parasympathetic activity. The pooled mean difference [mean difference (MD) = -0.18, 95%CI: -0.61 to 0.25; P = 0.41] indicated no significant change compared with controls. Heterogeneity was minimal (I2 = 0 %, τ2 = 0.00, P = 0.85); B: Meta-analysis for low-frequency (LF) heart-rate variability. Forest plot comparing omega-3 supplementation and control groups for LF power, representing mixed sympathetic and parasympathetic modulation. The pooled mean difference (MD = -4.59, 95%CI: -23.26 to 14.08; P = 0.63) showed no significant difference. No heterogeneity was observed (I2 = 64 %, τ2 = 127.15, P = 0.10); C: Meta-analysis for low- to high-frequency (LF/HF) ratio heart-rate variability. Forest plot illustrating between-group comparison of the LF/HF ratio following omega-3 supplementation. The pooled mean difference (MD = 0.95, 95%CI: -27.13 to 29.03; P = 0.95) demonstrated no significant change. However, heterogeneity was substantial (I2 = 93%, τ2 = 381.96, χ2 = 13.78, P = 0.0002), reflecting variability among included trials.


Write to the Help Desk